Allah Abadia A, Daykin J, Sheppard MC, Gough CSCL, Franklyn JA.2001. Radiological treatment of hyperthyroidism-progonostic factors for outcome. The Journal of Clinical Endocrinology & Metabolism, 86(3): 3611-3617.
Cooper DS, Doherty GM, Haugen BR, Kloos RT.2006. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. THYROID, 16(2): 109-141.
Cember H, Johnson TE.2009. Introduction to health physics, 4th Edition, McGraw-Hill, New York.
Firestone RB, Ekström LP.1999. LBNL Isotopes Project - LUNDS Universitet WWW Table of Radioactive Isotopes. Version 2.1,. The website: http://ie.lbl.gov/toi/nuclide.asp?iZA=530131.
Snyder W, Ford M, Warner G.1969. Estimates of absorbed fractions for monoenergetic photon source uniformly distributed in various organs of a heterogeneous phantom: MIRD pamphlet no. 5. J Nucl Med 10 (suppl 3):5–52.
Traino AC, di Martino F, Lazzeri M,. Stabin MG.2000. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves’ hyperthyroidism. Phys Med Biol 45: 121–129.
Vini L, Harmer C.2000. Radioiodine treatment for differentiated thyroid cancer. Clin Oncl (Rcoll Radiol), 12(6): 365-72.
Waters L S.2002. “MCNPX User’s Manual, version 2.3.0”, LA-UR-02-2607, Los Alamos, NM, USA